0
Skip to Content
Randy S. D’Amico, MD | Brain & Spine Tumor Surgery in New York City (NYC)
Home
About
Overview: Conditions I Treat
Glioblastoma and Glioma
Brain Metastases
Spine Metastases
Leptomeningeal Disease
Meningioma
Pituitary Tumors
Vestibular Schwannoma
Tumors Near Functional Networks
Second Opinion
Blog
Contact
Schedule a Consultation/Refer a patient
Randy S. D’Amico, MD | Brain & Spine Tumor Surgery in New York City (NYC)
Home
About
Overview: Conditions I Treat
Glioblastoma and Glioma
Brain Metastases
Spine Metastases
Leptomeningeal Disease
Meningioma
Pituitary Tumors
Vestibular Schwannoma
Tumors Near Functional Networks
Second Opinion
Blog
Contact
Schedule a Consultation/Refer a patient
Home
About
Folder: Conditions I Treat
Back
Overview: Conditions I Treat
Glioblastoma and Glioma
Brain Metastases
Spine Metastases
Leptomeningeal Disease
Meningioma
Pituitary Tumors
Vestibular Schwannoma
Tumors Near Functional Networks
Second Opinion
Blog
Contact
Schedule a Consultation/Refer a patient
Dr. D’Amico treats complex, high-risk, or previously deemed inoperable brain tumors.

Randy S. D’Amico, MD, FAANS, FCNS

Brain and Spine Tumor Surgeon - NYC

Advanced Tumor Surgery | Connectomics-Guided Precisions | Second Opinions

About Contact Follow

212-434-3900

Randy S. D’Amico, MD, FAANS, FCNS, is a leading neurosurgical oncologist at Lenox Hill Hospital in Manhattan and Director of Northwell Health’s Brain & Spine Metastasis Program. He specializes in the surgical treatment of brain metastases, spinal metastases, leptomeningeal disease, gliomas, meningiomas, and complex or recurrent brain tumors.

Dr. D’Amico’s practice combines advanced tumor surgery with emerging technologies—including structural and functional connectomics, awake brain mapping, minimally invasive approaches, and AI-enabled surgical planning. His goal is simple: deliver the safest, most precise tumor surgery possible while protecting the brain networks responsible for speech, movement, and cognition.

Based on the Upper East Side of New York City, Dr. D’Amico provides care for patients across Manhattan, Brooklyn, Queens, the Bronx, Long Island, and the broader tri-state area. He frequently evaluates patients seeking second opinions, especially those diagnosed with tumors considered inoperable or too high-risk.

As Director of the Lenox Hill Brain and Spine Metastasis Program, Dr. D’Amico collaborates closely with neuro-oncology, radiation oncology, medical oncology, neuroradiology, and supportive care teams. He also leads multiple clinical trials and research efforts focused on network-preserving neurosurgery, connectome-guided tumor resection, and innovative surgical technologies.

Dr. D’Amico is one of the few neurosurgeons in the country using structural and functional connectomics for personalized tumor resection, especially in eloquent and high-risk regions.

Whether you are newly diagnosed or exploring treatment options, Dr. D’Amico provides clear communication, evidence-based recommendations, and expedited access to expert care in the heart of New York City.

If you are seeking a second opinion or want to schedule a consultation, you can do so through Lenox Hill Hospital or reach out directly through the contact form below. Patients often seek a second opinion to confirm treatment options, review imaging, and understand whether advanced techniques such as connectomics-guided resection or minimally invasive approaches are appropriate. Dr. D’Amico offers rapid, thorough second opinions for newly diagnosed, complex, and recurrent brain tumors.

Common conditions evaluated and treated at our New York City practice include:

Brain metastases | Spinal metastases | Leptomeningeal disease | Glioma (low-grade and high-grade) | Meningioma | Recurrent or previously irradiated tumors | Tumors near critical functional networks | Tumors requiring awake brain surgery | Skull base tumors | Complex or “inoperable” tumors

Approach / Expertise

Connectomics-guided resection | Awake brain mapping | Minimally invasive approaches | Second opinions

Link to Socials and Media